Clinical Trial Update: Preliminary Study of CXCL3 As a Biomarker of Diabetic Kidney Disease [NA]

View source ↗

Summary

This update reports a preliminary clinical study investigating CXCL3 as a biomarker for diabetic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Diabetic Kidney Disease (DKD) | NA | Status: COMPLETED